Prevention of distant lung metastasis after photodynamic therapy application in a breast cancer tumor model

Journal of Biomedical Nanotechnology

Volumn 12, Issue 4, 2016, Pages 689-699

  Longo, Joao Paulo Figueiro ^a   Muehlmann, Luis Alexandre ^a   Miranda Vilela, Ana Luisa ^b   Portilho, Flavia Arruda ^a   De Souza, Ludmilla Regina ^a   Silva, Jaqueline Rodrigues ^a   Lacava, Zulmira Guerrero Marques ^a   Bocca, Anamelia Lorenzetti ^a   Chaves, Sacha Braun ^a   Azevedo, Ricardo Bentes ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b Faculty of Medicine   (Brazil)

Author keywords

Breast Cancer; Liver Hematopoiesis; Lung Metastasis; Myeloid Derived Suppressor Cells; Photodynamic Therapy; Polymeric Nanoparticle

Indexed keywords

BIOLOGICAL ORGANS; BLOOD; CELLS; CYTOLOGY; DISEASES; MAMMALS; PATHOLOGY; PATIENT MONITORING; PATIENT TREATMENT; POLYMERS; TUMORS;

BREAST CANCER; BREAST CANCER TUMORS; DISTANT METASTASIS; HEMATOPOIETIC CELL; LUNG METASTASIS; METHYL VINYL ETHER; OVERALL SURVIVAL; POLYMERIC NANOPARTICLES;

PHOTODYNAMIC THERAPY;

ALUMINUM CHLORO PHTHALOCYANINE; CYTOKERATIN AE1; METHYL VINYL ETHER CO MALEIC ANHYDRIDE; NANOCARRIER; PHTHALOCYANINE DERIVATIVE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG; CHLOROALUMINUM PHTHALOCYANINE; INDOLE DERIVATIVE; MALEIC ACID DERIVATIVE; NANOCAPSULE; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; POLY(METHYL VINYL ETHER-CO-MALEIC ANHYDRIDE); POLYETHYLENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; DISTANT METASTASIS; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HEMATOPOIETIC CELL; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PERITUMORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; POLYMERIZATION; SUPPRESSOR CELL; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; LUNG NEOPLASMS; PATHOLOGY; RADIATION RESPONSE; SECONDARY; TREATMENT OUTCOME; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL SURVIVAL; FEMALE; INDOLES; LUNG NEOPLASMS; MALEATES; MICE; MICE, INBRED BALB C; NANOCAPSULES; ORGANOMETALLIC COMPOUNDS; PHOTOSENSITIZING AGENTS; POLYETHYLENES; TREATMENT OUTCOME;

EID: 84961752967     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2016.2208     Document Type: Article

References (36)

1. D. R. Youlden, S. M. Cramb, N. A. Dunn, J. M. Muller, C. M. Pyke, and P. D. Baade, The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality. Cancer Epidemiology 36, 237 (2012).
2. C. DeSantis, R. Siegel, P. Bandi, and A. Jemal, Breast cancer statistics, 2011. CA: A Cancer Journal for Clinicians 61 408 (2011).
3. A. E. Giuliano, K. K. Hunt, K. V. Ballman, P. D. Beitsch, P. W. Whitworth, P. W. Blumencranz, A. M. Leitch, S. Saha, L. M. McCall, and M. Morrow, Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. Jama 305, 569 (2011).
4. F. Cardoso, N. Harbeck, L. Fallowfield, S. Kyriakides, and E. Senkus, Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 23, 11 (2012).
5. R. Allison, C. Sibata, G. Downie, and R. Cuenca, Photodynamic therapy of the intact breast. Photodiagnosis and Photodynamic Therapy 3, 139 (2006).
6. R. Allison, C. Sibata, T. Mang, V. Bagnato, G. Downie, X. Hu, and R. Cuenca, Photodynamic therapy for chest wall recurrence from breast cancer. Photodiagnosis and Photodynamic Therapy 1, 157 (2004).
7. P. Wyss, V. Schwarz, D. Dobler-Girdziunaite, R. Hornung, H. Walt, A. Degen, and M. Fehr, Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. International Journal of Cancer 93, 720 (2001).
8. D. E. Dolmans, D. Fukumura, and R. K. Jain, Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380 (2003).
9. A. P. Castano, T. N. Demidova, and M. R. Hamblin, Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis and Photodynamic Therapy 1, 279 (2004).
10. L. Muehlmann, G. Joanitti, J. Silva, J. P. F. Longo, and R. B. Azevedo, Liposomal photosensitizers: Potential platforms for anticancer photodynamic therapy. Brazilian Journal of Medical and Biological Research 44, 729 (2011).
11. L. A. Muehlmann, B. C. Ma, J. P. F. Longo, M. d. F. M. A. Santos, and R. B. Azevedo, Aluminum-phthalocyanine chloride associated to poly (methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy. International Journal of Nanomedicine 9, 1199 (2014).
12. T. Tammela, A. Saaristo, T. Holopainen, S. Ylä-Herttuala, L. C. Andersson, S. Virolainen, I. Immonen, and K. Alitalo, Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Science Translational Medicine 3, 1 (2011).
13. L. S. Bicalho, J. P. F. Longo, C. E. O. Cavalcanti, A. R. Simioni, A. L. Bocca, M. F. M. A. Santos, A. C. Tedesco, and R. B. Azevedo, Photodynamic therapy leads to complete remission of tongue tumors and inhibits metastases to regional lymph nodes. J. Biomed. Nan-otechnol. 9, 811 (2013).
14. M. Korbelik, Induction of tumor immunity by photodynamic therapy. Journal of Clinical Laser Medicine and Surgery 14, 329 (1996).
15. A. P. Castano, P. Mroz, and M. R. Hamblin, Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer 6, 535 (2006).
16. D. I. Gabrilovich and S. Nagaraj, Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162 (2009).
17. F. Cardoso, E. Senkus-Konefka, L. Fallowfield, A. Costa, and M. Castiglione, Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21, 15 (2010).
18. D. Hanahan and R. A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646 (2011).
19. S. Kusmartsev and D. I. Gabrilovich, Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunology, Immunotherapy 55, 237 (2006).
20. J. Finke, S. Ferrone, A. Frey, A. Mufson, and A. Ochoa, Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunology Today 20, 158 (1999).
21. A. A. Hurwitz and S. K. Watkins, Immune suppression in the tumor microenvironment: A role for dendritic cell-mediated tolerization of T cells. Cancer Immunology, Immunotherapy 61, 289 (2012).
22. D. Lindau, P. Gielen, M. Kroesen, P. Wesseling, and G. J. Adema, The immunosuppressive tumour network: Myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 138, 105 (2013).
23. L. J. Bayne, G. L. Beatty, N. Jhala, C. E. Clark, A. D. Rhim, B. Z. Stanger, and R. H. Vonderheide, Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822 (2012).
24. D. Ilkovitch and D. M. Lopez, The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppres-sion. Cancer Research 69, 5514 (2009).
25. P. Trikha and W. E. Carson, Signaling pathways involved in MDSC regulation. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846, 55 (2014).
26. A. M. Müller, A. Medvinsky, J. Strouboulis, F. Grosveld, and E. Dzierzakt, Development of hematopoietic stem cell activity in the mouse embryo. Immunity, 1, 291 (1994).
27. M. J. Kiel and S. J. Morrison, Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol. 8, 290 (2008).
28. M. K. Connolly, J. M.-S. Clair, A. S. Bedrosian, A. Malhotra, V. Vera, J. Ibrahim, J. Henning, H. L. Pachter, D. Bar-Sagi, and A. B. Frey, Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. Journal of Leukocyte Biology 87, 713 (2010).
29. I. H. Younos, A. J. Dafferner, D. Gulen, H. C. Britton, and J. E. Talmadge, Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking. International Immunopharmacol-ogy 13, 245 (2012).
30. Y. Sawanobori, S. Ueha, M. Kurachi, T. Shimaoka, J. E. Talmadge, J. Abe, Y. Shono, M. Kitabatake, K. Kakimi, and N. Mukaida, Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111, 5457 (2008).
31. M. Korbelik, J. Sun, and I. Cecic, Photodynamic therapy-induced cell surface expression and release of heat shock proteins: Relevance for tumor response. Cancer Research 65, 1018 (2005).
32. A. D. Garg, D. Nowis, J. Golab, and P. Agostinis, Photodynamic therapy: Illuminating the road from cell death towards anti-tumour immunity. Apoptosis 15, 1050 (2010).
33. V. P. Torchilin, Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discovery 4, 145 (2005).
34. J. P. F. Longo, L. N. D. de Melo, M. C. Mijan, C. R. A. Valois, G. A. Joanitti, A. R. Simioni, A. C. Tedesco, and R. B. de Azevedo, Photodynamic therapy mediated by liposomal chloroaluminum-phthalocyanine induces necrosis in oral cancer cells. J. Biomater. Tissue Eng. 3, 148 (2013).
35. M. Mijan, J. P. F.Longo, L. Melo, A. Simioni, A. C. Tedeco, and R. B. de Azevedo, Vascular shutdown and pro-inflammatory cytokine expression in breast cancer tumors after photodynamic therapy mediated by nano-sized liposomes containing aluminium-chloride-phthalocyanine. J. Nanomed. Nanotechnol. 5, 218 (2014).
36. J. P. F. Longo, S. P. Lozzi, A. R. Simioni, P. C. Morais, A. C. Tedesco, and R. B. Azevedo, Photodynamic therapy with aluminum-chloro-phtalocyanine induces necrosis and vascular damage in mice tongue tumors. Journal of Photochemistry and Photobiology B: Biology 94, 143 (2009).